Clinical trials
Observational Condylomata Acuminata trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankara City Hospital Bilkent | 1 |
| BEMFAM-Bem Estar Familiar | 1 |
| Duke University | 1 |
| Integra LifeSciences Corporation | 1 |
| Jun Zhang | 1 |
| Juna d.o.o. | 1 |
| Kaohsiung Medical University Chung-Ho Memorial Hospital | 1 |
| La Fundacion para la Investigacion y el Desarrollo | 1 |
| Lisen Arnheim Dahlstrom | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Condylomata Acuminata | 20 |
| Papillomavirus Infections | 7 |
| Uterine Cervical Neoplasms | 7 |
| Uterine Cervical Dysplasia | 3 |
| Vaginal Neoplasms | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| DNA Virus Infections | 1 |
| Giardiasis | 1 |
| Gonorrhea | 1 |
| HIV Infections | 1 |
Trials
Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.